Skip Navigation
Skip to contents

Ann Coloproctol : Annals of Coloproctology

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
10 "Transanal endoscopic microsurgery"
Filter
Filter
Article category
Keywords
Publication year
Authors
Display
Original Articles
Minimally invasive surgery
Minimally invasive transanal excision for rectal tumors: technical feasibility compared to conventional approach
Ji Yeon Mun, Gyu Sung Geong, Nina Yoo, Hyung Jin Kim, Hyeon-Min Cho, Bong-Hyeon Kye
Ann Coloproctol. 2025;41(2):162-168.   Published online April 29, 2025
DOI: https://doi.org/10.3393/ac.2024.00864.0123
  • 6,107 View
  • 145 Download
  • 1 Web of Science
  • 1 Citations
Graphical AbstractGraphical Abstract AbstractAbstract PDFSupplementary Material
Purpose
The technique for transanal resection of rectal tumors has evolved from conventional methods to minimally invasive approaches. However, the research comparing long-term results between these approaches is limited.
Methods
Between 2016 and 2022, a total of 133 patients who underwent transanal excision were analyzed. Patients were classified into 2 groups according to surgical approach: conventional transanal approach (CTA) and minimally invasive transanal approach (MTA). Medical records were analyzed to compare surgical and oncological outcomes between the 2 groups.
Results
There were no significant differences observed in patient’s demographics and tumor characteristics, except the MTA group exhibited a statistically longer distance from the anal verge. Although statistical significance was not reached, the MTA group demonstrated a 100% margin-negative rate in contrast to the CTA group, which had worse outcomes for both margin status and fragmentation. Recurrence was observed only in the CTA group containing pT1 rectal cancer and grade 1 neuroendocrine tumor, with negative margins and no fragmentation.
Conclusion
The minimally invasive approach did not demonstrate statistical superiority but showed technical feasibility through the absence of margin-positive cases and the use of the clip handle method. Further studies are needed to validate these findings and assess broader applicability.

Citations

Citations to this article as recorded by  
  • Minimally invasive transanal excision over conventional transanal excision: pursuing the perfect removal of early rectal cancer
    HyungJoo Baik
    Annals of Coloproctology.2025; 41(2): 105.     CrossRef
Anorectal physiology & pelvic floor disorder
Does transanal endoscopic microsurgery affect rectal function?
Evgeniy Khomyakov, Stanislav Chernyshov, Oksana Fomenko, Evgeny Rybakov
Ann Coloproctol. 2023;39(4):326-331.   Published online November 14, 2022
DOI: https://doi.org/10.3393/ac.2022.00220.0031
  • 4,370 View
  • 67 Download
  • 2 Web of Science
  • 2 Citations
AbstractAbstract PDF
Purpose
Transanal endoscopic microsurgery (TEM) is the most standardized method for the local excision of rectal neoplasms. Unfortunately, local excisions of rectal lesions by means of TEM are not completely free from undesirable functional sequela. This study was performed to evaluate the risk factors of major loss of function after TEM.
Methods
Eighty-nine patients underwent TEM between 2019 and 2020. Anorectal manometry was performed before the surgery and 3, 6, and 12 months after the surgery. The quality of life (QoL) was assessed using the Fecal Incontinence Quality of Life scale.
Results
The major decrease in QoL was observed in women in 3 months after the surgery in terms of lifestyle and frustration domains (3.6 and 3.64 points, respectively). In 3 months after the surgery, there was a significant decrease in resting pressure both in male and female patients (P=0.01). This difference remained significant 6 months after the surgery (P=0.01). In 12 months after the surgery, resting pressure returned to the preoperative level in most patients (P=0.50). A significant decrease in manometric parameters appeared when the surgery time is more than 55 minutes (P=0.05), the tumor localization is lower than 3 cm from the anus (P=0.03), and the tumor size is over 3 cm (P=0.001).
Conclusion
The most significant risk factors for the development of functional disorders after TEM are surgery time of >55 minutes, tumor localization at <3 cm from the anal verge, and tumor size of >3 cm.

Citations

Citations to this article as recorded by  
  • For Early Rectal Neoplasms, the Time Has Come to Move Beyond the Transanal Minimally Invasive Surgery Era: Endoscopic Submucosal Dissection Is No Longer the Challenger—It Is the Standard to Beat
    Jeremie Jacques, Jon Steingrimsson
    Gastroenterology.2026; 170(1): 14.     CrossRef
  • Beyond survival: a comprehensive review of quality of life in rectal cancer patients
    Won Beom Jung
    Annals of Coloproctology.2024; 40(6): 527.     CrossRef
Case Reports
Malignant disease
Transanal Endoscopic Microsurgery: Endoscopy Assisted Treatment of Colorectal Anastomotic Stenosis
Giancarlo D'Ambrosio, Antonietta Lamazza, Rossella Palma, Andrea Picchetto, Cristina Panetta, Antonello Trecca, Stefano Pontone, Emanuele Lezoche
Ann Coloproctol. 2020;36(4):285-288.   Published online March 16, 2020
DOI: https://doi.org/10.3393/ac.2019.09.30.3
  • 7,120 View
  • 136 Download
  • 3 Web of Science
  • 4 Citations
AbstractAbstract PDF
Transanal endoscopic microsurgery (TEM) is a type of natural orifice transluminal endoscopic surgery, developed for rectal tumors and used also to treat other rectal diseases. Anastomotic complications after colorectal surgery, including stenosis, represent a challenging problem. We present the case of a 36-year-old woman with a diagnosis of Hirschsprung disease that was submitted to a modified Duhamel operation. A postoperative barium enema showed a complete stricture of the anastomosis that was impossible to resolve by flexible endoscopic approach. Then an intraoperative endoscopic approach to facilitate the localization of preanastomotic colon (proximal colon from the anastomosis) was performed by a small colotomy and the colonic recanalization was obtained by the creation of a neo-anastomosis by TEM, under fluoroscopic-endoscopic control. The patient underwent a control barium enema showing regular retrograde transit of contrast medium without evidence of stenosis. In our experience, transanal approach by TEM-colonoscopy assisted is safe and feasible and represents a model of combined minimally invasive technique.

Citations

Citations to this article as recorded by  
  • Application of transurethral prostate resection instrumentation for treating rectal anastomotic stenosis: Case series
    Wenshan Xu, Yujie Qin, Faying Yang, Jun Qian, Yanbo Dong, Song Tu, Jiaxi Yao
    Medicine.2023; 102(19): e33799.     CrossRef
  • Eight Years Experience of Transanal Endoscopic Microsurgery
    Seyed Vahid Hosseini, Mohammad Rezazadehkermani, Ali Abdulridha Abbas Algharah, Alimohammad Bananzadeh, Seyedeh Saeideh Shahidinia, Mehrdad Haghazali
    Journal of Coloproctology.2023; 43(04): e251.     CrossRef
  • Transanal Minimally Invasive Surgery for Rectal Anastomotic Stenosis After Colorectal Cancer Surgery
    Wei Zhou, Lian Xia, Zian Wang, Gaoyang Cao, Li Chen, Engeng Chen, Wei Zhang, Zhangfa Song
    Diseases of the Colon & Rectum.2022; 65(8): 1062.     CrossRef
  • Application of endoscopic technique in completely occluded anastomosis with anastomotic separation after radical resection of colon cancer: a case report and literature review
    Junnan Gu, Shenghe Deng, Yinghao Cao, Fuwei Mao, Hang Li, Huili Li, Jiliang Wang, Ke Wu, Kailin Cai
    BMC Surgery.2021;[Epub]     CrossRef
Pneumoretroperitoneum and Sepsis After Transanal Endoscopic Resection of a Rectal Lateral Spreading Tumor
Bruno Augusto Alves Martins, Marcelo de Melo Andrade Coura, Romulo Medeiros de Almeida, Natascha Mourão Moreira, João Batista de Sousa, Paulo Gonçalves de Oliveira
Ann Coloproctol. 2017;33(3):115-118.   Published online June 30, 2017
DOI: https://doi.org/10.3393/ac.2017.33.3.115
  • 5,786 View
  • 45 Download
  • 3 Web of Science
  • 5 Citations
AbstractAbstract PDF

Transanal endoscopic microsurgery is considered a safe, appropriate, and minimally invasive approach, and complications after endoscopic microsurgery are rare. We report a case of sepsis and pneumoretroperitoneum after resection of a rectal lateral spreading tumor. The patient presented with rectal mucous discharge. Colonoscopy revealed a rectal lateral spreading tumor. The patient underwent an endoscopic transanal resection of the lesion. He presented with sepsis of the abdominal focus, and imaging tests revealed pneumoretroperitoneum. A new surgical intervention was performed with a loop colostomy. Despite the existence of other reports on pneumoretroperitoneum after transanal endoscopic microsurgery, what draws attention to this case is the association with sepsis.

Citations

Citations to this article as recorded by  
  • Massive pneumoperitoneum and subcutaneous emphysema after transanal resection of a rectal tumor: Case report and comprehensive review of the literature
    P Bretcha Boix, Marie Stephanie Nunez Duarte, A Dieter, R Silver
    Journal of Case Reports and Images in Surgery.2025; 11(1): 31.     CrossRef
  • Emphysema as a complication after transanal endoscopic microsurgery (TEM) (case report and review)
    E. A. Khomyakov, T. A. Eryshova, M. V. Kapitanov, S. V. Chernyshov, E. G. Rybakov
    Koloproktologia.2023; 22(4): 113.     CrossRef
  • Approach to the patient with pneumoretroperitoneum
    Sumudu Welikumbura, Toan Pham, Anshini Jain, Marli Williams, Philip Smart
    ANZ Journal of Surgery.2021; 91(1-2): 206.     CrossRef
  • Penetration into free abdominal cavity during transanal endoscopic rectal resection for adenoma
    Yu. A. Gevorkyan, N. V. Soldatkina, V. E. Kolesnikov, D. A. Kharagezov, A. V. Dashkov, S. I. Poluektov, N. S. Samoylenko
    South Russian Journal of Cancer.2021; 2(1): 43.     CrossRef
  • Ectopic air localizations after transanal procedures: A systematic literature review
    Andrea Balla, Silvia Quaresima, Alessandro M. Paganini
    International Journal of Surgery.2018; 56: 167.     CrossRef
Original Articles
Transanal Endoscopic Microsurgery for Patients With Rectal Tumors: A Single Institution's Experience
Audrius Dulskas, Alfredas Kilius, Kestutis Petrulis, Narimantas E. Samalavicius
Ann Coloproctol. 2017;33(1):23-27.   Published online February 28, 2017
DOI: https://doi.org/10.3393/ac.2017.33.1.23
  • 6,886 View
  • 54 Download
  • 13 Web of Science
  • 15 Citations
AbstractAbstract PDF
Purpose

The purpose of this study was to look at our complication rates and recurrence rates, as well as the need for further radical surgery, in treating patients with benign and early malignant rectal tumors by using transanal endoscopic microsurgery (TEM).

Methods

Our study included 130 patients who had undergone TEM for rectal adenomas and early rectal cancer from December 2009 to December 2015 at the Department of Surgical Oncology, National Cancer Institute, Lithuania. Patients underwent digital and endoscopic evaluation with multiple biopsies. For preoperative staging, pelvic magnetic resonance imaging or endorectal ultrasound was performed. We recorded the demographics, operative details, final pathologies, postoperative lengths of hospital stay, postoperative complications, and recurrences.

Results

The average tumor size was 2.8 ± 1.5 cm (range, 0.5–8.3 cm). 102 benign (78.5%) and 28 malignant tumors (21.5%) were removed. Of the latter, 23 (82.1%) were pT1 cancers and 5 (17.9%) pT2 cancers. Of the 5 patients with pT2 cancer, 2 underwent adjuvant chemoradiotherapy, 1 underwent an abdominoperineal resection, 1 refused further treatment and 1 was lost to follow up. No intraoperative complications occurred. In 7 patients (5.4%), postoperative complications were observed: urinary retention (4 patients, 3.1%), postoperative hemorrhage (2 patients, 1.5%), and wound dehiscence (1 patient, 0.8%). All complications were treated conservatively. The mean postoperative hospital stay was 2.3 days.

Conclusion

TEM in our experience demonstrated low complication and recurrence rates. This technique is recommended for treating patients with a rectal adenoma and early rectal cancer and has good prognosis.

Citations

Citations to this article as recorded by  
  • TEMPOUR: A Randomized Controlled Trial Assessing Perioperative Use of an Alpha-1 Blocker to Reduce Postoperative Urinary Retention After Transanal Endoscopic Microsurgery Procedures
    Thomas Couture, Claudya Morin, Janyssa Charbonneau, Émilie Papillon-Dion, Alexandre Bouchard, François Rouleau-Fournier, Philippe Bouchard, François Letarte, Alexis F. Turgeon, Sebastien Drolet
    Diseases of the Colon & Rectum.2025; 68(4): 475.     CrossRef
  • The Outcome of Local Excision of Rectal Adenomas with High-Grade Dysplasia by Transanal Endoscopic Microsurgery: A Single-Center Experience
    Muhammad Khalifa, Rachel Gingold-Belfer, Nidal Issa
    Journal of Clinical Medicine.2024; 13(5): 1419.     CrossRef
  • Transanal endoscopic rectal resection: immediate and long-term results
    A.A. Maslov, Yu.A. Gevorkyan, N.V. Soldatkina, A.V. Dashkov, S.I. Poluektov, V.E. Kolesnikov, D.O. Kaymakchi, A.V. Snezhko
    Khirurgiya. Zhurnal im. N.I. Pirogova.2022; (1): 30.     CrossRef
  • Complex Procedures in Transanal Endoscopic Microsurgery: Intraperitoneal Entry, Ultra Large Rectal Tumors, High Lesions, and Resection in the Anal Canal
    Xavier Serra-Aracil, Victoria Lucas-Guerrero, Laura Mora-López
    Clinics in Colon and Rectal Surgery.2022; 35(02): 129.     CrossRef
  • Multidisciplinary treatment strategy for early rectal cancer
    Gyung Mo Son, In Young Lee, Sung Hwan Cho, Byung-Soo Park, Hyun Sung Kim, Su Bum Park, Hyung Wook Kim, Sang Bo Oh, Tae Un Kim, Dong Hoon Shin
    Precision and Future Medicine.2022; 6(1): 32.     CrossRef
  • Is Local Resection of Anal Canal Tumors Feasible with Transanal Endoscopic Surgery?
    Xavier Serra‐Aracil, Andrea Campos‐Serra, Laura Mora‐López, Sheila Serra‐Pla, Anna Pallisera‐Lloveras, Roser Flores‐Clotet, Alba Zárate‐Pinedo, Salvador Navarro‐Soto
    World Journal of Surgery.2020; 44(3): 939.     CrossRef
  • Transanal endoscopic microsurgery for a rectal polyp – a video vignette
    N. E. Samalavicius, P. Kavaliauskas, A. Dulskas
    Colorectal Disease.2020; 22(9): 1203.     CrossRef
  • Endoscopic diagnosis of gastrointestinal melanoma
    Sheng Wang, Siyu Sun, Xiang Liu, Nan Ge, Guoxin Wang, Jintao Guo, Wen Liu, Jinlong Hu
    Scandinavian Journal of Gastroenterology.2020; 55(3): 330.     CrossRef
  • Is Previous Transanal Endoscopic Microsurgery for Early Rectal Cancer a Risk Factor of Worse Outcome following Salvage Surgery A Case-Matched Analysis
    Audrius Dulskas, Aivaras Atkociunas, Alfredas Kilius, Kestutis Petrulis, Narimantas E. Samalavicius
    Visceral Medicine.2019; 35(3): 151.     CrossRef
  • Transanal endoscopic microsurgery for rectal lesions in a specialist regional early rectal cancer centre: the Mersey experience
    M. Ondhia, P. Tamvakeras, P. O'Toole, A. Montazerri, T. Andrews, C. Farrell, S. Ahmed, S. Slawik, S. Ahmed
    Colorectal Disease.2019; 21(10): 1164.     CrossRef
  • Transanal Endoscopic Microsurgery for Patients with Rare Rectal Tumors
    Xin Wu, Guole Lin, Huizhong Qiu, Jiaolin Zhou
    Journal of Laparoendoscopic & Advanced Surgical Techniques.2018; 28(5): 546.     CrossRef
  • Modern management of T1 rectal cancer by transanal endoscopic microsurgery: a 10‐year single‐centre experience
    H. J. S. Jones, R. Hompes, N. Mortensen, C. Cunningham
    Colorectal Disease.2018; 20(7): 586.     CrossRef
  • Transanal endoscopic microsurgery as day surgery – a single‐centre experience with 500 patients
    C. J. Brown, J. Q. Gentles, T. P. Phang, A. A. Karimuddin, M. J. Raval
    Colorectal Disease.2018;[Epub]     CrossRef
  • Transanal Endoscopic Microsurgery
    Byung Chun Kim
    Annals of Coloproctology.2017; 33(1): 5.     CrossRef
  • Transanal endoscopic microsurgery for giant benign rectal tumours: is large size a contraindication?
    Audrius Dulskas, Alfredas Kilius, Kestutis Petrulis, Narimantas E. Samalavicius
    International Journal of Colorectal Disease.2017; 32(12): 1759.     CrossRef
Transanal Endoscopic Microsurgery for the Treatment of Well-Differentiated Rectal Neuroendocrine Tumors
Hyoung Ran Kim, Woo Yong Lee, Kyung Uk Jung, Hyuk Jun Chung, Chul Joong Kim, Hae-Ran Yun, Yong Beom Cho, Seong Hyeon Yun, Hee Cheol Kim, Ho-Kyung Chun
J Korean Soc Coloproctol. 2012;28(4):201-204.   Published online August 31, 2012
DOI: https://doi.org/10.3393/jksc.2012.28.4.201
  • 6,287 View
  • 35 Download
  • 10 Citations
AbstractAbstract PDF
Purpose

Recently, an increase in well-differentiated rectal neuroendocrine tumors (WRNETs) has been noted. We aimed to evaluate transanal endoscopic microsurgery (TEM) for the treatment of WRNETs.

Methods

Between December 1995 and August 2009, 109 patients with WRNETs underwent TEM. TEM was performed for patients with tumors sizes of up to 20 mm and without a lymphadenopathy. These patients had been referred from other clinics after having been diagnosed with WRNETs by using a colonoscopic biopsy; they had undergone a failed endoscopic submucosal dissection (ESD) or endoscopic mucosal resection (EMR) and exhibited an involved resection margin and remaining tumor after ESD or EMR, regardless of the distance from the anal verge. This study included 38 patients that had more than three years of follow-up.

Results

The mean age of the patients was 51.3 ± 11.9 years, the mean tumor size was 8.0 ± 3.9 mm, and no morbidity occurred. Thirty-five patients were asymptomatic. TEM was performed after a colonoscopic resection in 13 cases because of a positive resection margin, a residual tumor or a non-lifting lesion. Complete resections were performed in 37 patients; one patient with a positive margin was considered surgically complete. In one patient, liver metastasis and a recurrent mesorectal node occurred after five and 10 years, respectively.

Conclusion

TEM might provide an accessible and effective treatment either as an initial or as an adjunct after a colonoscopic resection for a WRNET.

Citations

Citations to this article as recorded by  
  • Transanal endoscopic microsurgery in the treatment of rectal neuroendocrine tumors: a retrospective 10-year single-center experience
    Marek Szczepkowski, Piotr Witkowski, Alicja Przywózka-Suwała, Karolina Skonieczna-Żydecka, Teresa Starzyńska, Krzysztof Dąbkowski
    Langenbeck's Archives of Surgery.2025;[Epub]     CrossRef
  • Endoscopic Submucosal Dissection and Transanal Endoscopic Microsurgery in the Treatment of Rectal Neuroendocrine Tumors: Systematic Review and Meta-Analysis of the Observational Studies
    Krzysztof Dąbkowski, Karolina Skonieczna-Żydecka, Katarzyna Gaweł, Wojciech Marlicz, Piotr Szredzki, Andrzej Białek
    Clinical and Translational Gastroenterology.2025; 16(10): e00882.     CrossRef
  • Oncological outcomes according to the treatment modality based on the size of rectal neuroendocrine tumors: a single-center retrospective study
    Jimin Son, In Ja Park, Dong-Hoon Yang, Jisup Kim, Kyoung-Jo Kim, Jeong-Sik Byeon, Seung Mo Hong, Young Il Kim, Jong Beom Kim, Seok-Byung Lim, Chang Sik Yu, Jin Cheon Kim
    Surgical Endoscopy.2022; 36(4): 2445.     CrossRef
  • Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors
    Wei-Kun Shi, Rui Hou, Yun-Hao Li, Xiao-Yuan Qiu, Yu-Xin Liu, Bin Wu, Yi Xiao, Jiao-Lin Zhou, Guo-Le Lin
    BMC Surgery.2022;[Epub]     CrossRef
  • Non-conventional applications for transanal endoscopic microsurgery. A single center experience and a systematic review of literature
    Rosita DE VINCENTI, Fabio CIANCHI, Francesco CORATTI
    Minerva Surgery.2022;[Epub]     CrossRef
  • Transanalis műtéti útmutató – második kiadás
    Kálmán Almási, Szabolcs Ábrahám, József Baracs, Attila Bursics, Zoltán Jánó, Tamás Sztipits, Áron Szűts, Dezső Tóth, Attila Zaránd, Balázs Bánky
    Orvosi Hetilap.2022; 163(Supplement): 3.     CrossRef
  • Endoscopic submucosal dissection versus transanal local excision for rectal carcinoid: a comparative study
    Fei-hu Yan, Zheng Lou, Shi-jie Hu, Xiao-dong Xu, Hao Wang, Han-tao Wang, Rong-gui Meng, Chuan-gang Fu, Wei Zhang, Jian He, En-da Yu
    World Journal of Surgical Oncology.2016;[Epub]     CrossRef
  • Efficacy and Safety of Endoscopic Resection Therapies for Rectal Carcinoid Tumors: A Meta-Analysis
    Lei He, Tao Deng, Hesheng Luo
    Yonsei Medical Journal.2015; 56(1): 72.     CrossRef
  • Full-thickness excision using transanal endoscopic microsurgery for treatment of rectal neuroendocrine tumors
    Wei-Jie Chen
    World Journal of Gastroenterology.2015; 21(30): 9142.     CrossRef
  • Current Issues Involving the Treatment of Small Rectal Carcinoid Tumors
    Dae Kyung Sohn
    Journal of the Korean Society of Coloproctology.2012; 28(4): 176.     CrossRef
Therapeutic Results of Transanal Endoscopic Microsurgery and Radical Surgery for T1, T2 Rectal Cancer.
Lee, Doo Seok , Choi, Sung Il , Chang, Weon Young , Lee, Wooyong , Chun, HoKyung
J Korean Soc Coloproctol. 2002;18(4):240-245.
  • 1,681 View
  • 20 Download
AbstractAbstract PDF
PURPOSE
Transanal endoscopic microsurgery (TEM) has gained increasing acceptance as a treatment of choice for early rectal cancer. The purpose of this study was to compare the results of TEM and radical surgery in patients with T1 and T2 rectal cancer.
METHODS
From October 1994 to December 2000, 74 patients with T1 and T2 rectal adenocarcinoma treated with TEM were compared with 100 patients with T1N0M0 and T2N0M0 rectal adenocarcinoma treated with radical surgery. Retrospective analysis was made regarding to recurrence and survival rate. Neither group received adjuvant chemo-radiation. There was no significant difference in age, gender, tumor location and follow-up period between two groups, except tumor size.
RESULTS
Of 74 patients in TEM group, 52 patients were T1 (70.3%) and 22 patients were T2 (29.7%). Of 100 patients in radical surgery group, 17 patients were T1 (17.0%) and 83 patients were T2 (83.0%). Five-year local recurrence rates were 4.1% for T1, 19.5% for T2 after TEM, 0% for T1 and 9.4% for T2 after radical surgery. There was no statistical difference between T1 rectal cancer (P=0.95), but in T2 rectal cancer, it was higher after TEM than after radical surgery (P=0.04). Five-year disease free survival rates showed no statistical difference between two groups (TEM group: 95.9% for T1, 80.5% for T2, radical surgery group: 94.1% for T1, 83.3%for T2; P=0.35, P=0.12). Five-year survival rate were 100% for T1, 94.7% for T2 after TEM and 92.9% for T1, 96.1% for T2 after radical surgery. There were no significant statistical difference between two groups (P=0.07, P=0.48).
CONCLUSIONS
In T1 rectal cancer, there were no difference in recurrence and five-year survival rate between TEM and radical surgery group. In T2 rectal cancer, five-year survival rate showed no statistical difference between two groups, but TEM carried higher risk of local recurrence. Therefore careful selection of the patients is required for TEM and when proper muscle invasion is proven after TEM, further treatment should be considered.
Clinical Results of Transanal Endoscopic Microsurgery (TEM).
Chung, Jun Chul , Choi, Sung Il , Lee, Doo Suk , Chang, Weon Young , Noh, Sang Ik , Oh, So Hyang , Lee, Woo Yong , Chun, Ho Kyung
J Korean Soc Coloproctol. 2002;18(2):104-109.
  • 1,527 View
  • 11 Download
AbstractAbstract PDF
PURPOSE
Local treatment of rectal tumors have become an alternative to the classic radical operation. However, conventional transanal procedures are limited to tumors located in the lower rectum and the precision of the excision is restricted by the limitation of the surgeon's visualization during the procedure. This report will present our surgical management and functional results after TEM, a new minimally invasive technique for the treatment of rectal tumors.
METHODS
From December 1994 to January 2000, 136 patients underwent TEM. All patients were evaluated preoperatively with sigmoidoscopy or colonoscopy with biopsy. The indications for TEM were benign rectal tumors and T1 and T2 malignant rectal tumors with well or moderately differentiation. All patients were followed up 1 month postoperatively and every 3 months thereafter.
RESULTS
The mean operation time was 56.5 minutes (25~150 minutes) and the mean postoperative hospital stay was 3.6 days (2~10 days). On the basis of the postoperative evaluations, 56 of the 136 patients proved to have benign tumors while the remaining 80 patients had malignant tumors. One hundred thirty five patients were removed with adequate resection margins. One patient had cancer cell involvement at the resection margin. There were no serious complications. After a mean observation time of 29 months (12~42 months), there were five noted recurrences. Functional results were excellent; 24 of the 136 patients complained of impaired continence or defecation disorders in a review one month postoperatively. These problems improved during the first 6 months after the surgery.
CONCLUSIONS
We feel that TEM is an adequate method for removal of benign rectal tumors, and properly selected early rectal cancers.
Decision of Salvage Treatment after Transanal Endoscopic Microsurgery: Clinical Experience on 36 Cases of Rectal Cancer.
Shin, Suk Hee , Han, Sang Ah , Park, Chi Min , Yun, Seong Hyeon , Lee, Woo Yong , Choi, Dong Wook , Chun, Hokyung
J Korean Soc Coloproctol. 2005;21(6):406-412.
  • 1,389 View
  • 9 Download
AbstractAbstract PDF
PURPOSE
Local excision, including transanal endoscopic microsurgery (TEM), has become an alternative to the classic radical operation for early rectal cancer. However, radical resection for rectal cancer is necessary for advanced tumor, poor differentiation, a narrow resection margin, and positive lymphovascular invasion. This study presents the factors related to recurrence in patients who required secondary radical surgery after TEM, but did not undergo the operation.
METHODS
From November 1994 to December 2004, 167 patients underwent TEM for rectal cancer. Thirty-six of those patients were included in this study. Inclusion criteria were poor differentiation, a mucinous carcinoma, invasion to a proper muscle layer, lymphovascular invasion, and a positive resection margin.
RESULTS
Twelve of the 36 patients underwent a secondary radical operation, but 24 of them did not due to poor general condition or refusal. One of 12 patients (8.3%) who underwent a secondary radical operation had a systemic recurrence. Five of 24 patients (20.8%) who did not receive surgery had recurrences; 3 of 5 were local recurrence, and the others were distant metastases. Among the 24 patients who did not undergo a secondary radical operation, there were no recurrences in 2 cases of poor differentiation or mucinous carcinoma and in 2 cases of positive resection margin. There were 2 cases of recurrences in the 7 patients (25.0%) who had lymphovascular invasion, 1 case in the 1 patient (100%) who had a T3 lesion, 3 cases in the 17 patients (12.5%) who had T2 lesions.
CONCLUSIONS
In high-risk patients, TEM followed by radical surgery is most beneficial in preventing local recurrence. A radical operation is strongly recommended especially if pathologic results after TEM shows T3 lesions or lymphovascular invasion.
Transanal Endoscopic Microsurgery after Preoperative Concurrent Chemoradiation Therapy in Selected Distal Rectal Cancer Patients.
Park, Chi Min , Jung, Keuk Won , Han, Sang Ah , Yun, Seong Hyeon , Lee, Woo Yong , Chun, HoKyung
J Korean Soc Coloproctol. 2005;21(5):293-299.
  • 1,273 View
  • 8 Download
AbstractAbstract PDF
PURPOSE
Preoperative concurrent chemoradiation (CCRT) therapy may allow higher rates of tumor resectability and sphincter-saving procedures. Transanal endoscopic microsurgery (TEM) has become increasingly common in the management of selected patients with early rectal cancer. The aim of this study is to evaluate the clinical outcomes of selected patients with distal rectal cancer treated with TEM after CCRT.
METHODS
Between June 2000 and August 2004, 7 patients with clinically T2 or T3 rectal cancer underwent TEM after CCRT. Pretreatment and preoperative clinical stages were estimated by using endorectal ultrasound or computed tomography and digital rectal exam. CCRT was performed with radiation therapy of 4,500 cGy/25 fractions over 5 weeks with 5-FU based chemosensitization. TEM was performed 4~7 weeks following the completion of therapy.
RESULTS
The mean age was 54.9 (35~70) years and the median follow-up period was 23.0 (5~57) months. The lesions were located between 2 to 6 cm above the anal verge (median 3.0 cm). Pre- treatment T staging was estimated as T3 in 1 case and T2 in 6 cases, and post-treatment T staging was estimated as complete remission (CR) in 2 cases, T1 in 3 cases, and T2 in 2 patients. Pathologic evaluation revealed tumor downstaging in 6 patients, including 3 patients (42.9%) with CR. In all cases, there was no tumor on the resection margin. There have been no recurrences during the follow-up period.
CONCLUSIONS
TEM after CCRT therapy appears to be an effective alternative treatment to radical resection for highly selected patients with T2 and T3 distal rectal cancer.
  • FirstFirst
  • PrevPrev
  • Page of 1
  • Next Next
  • Last Last

Ann Coloproctol : Annals of Coloproctology Twitter Facebook
TOP